About Us

Background
In the summer of 2011, the Prevention Program Branch published Funding Opportunity Announcement PS12-1201, Category B: Expanded Human Immunodeficiency Virus (HIV) Testing for Disproportionately Affected Populations.

Main Features

PS12-1201 Category B includes two components:

Routine, opt-out HIV screening in healthcare settings serving the target populations (at least 70 percent of funding); and
Targeted HIV testing in non-healthcare venues frequented by high-risk individuals (up to 30 percent of funding).

Purpose:

Increase HIV testing opportunities for populations disproportionately affected by HIV - African-Americans, Hispanics, men who have sex with men (MSM) and injection drug users (IDUs), primarily in healthcare settings and expand targeted testing in non-healthcare settings and venues where high-risk members of these populations can be accessed.
Increase the proportion of HIV-infected persons in these populations who are aware of their infection and are linked to appropriate services, such as prevention counseling and HIV medical care, partner services, and HIV prevention services.
Integrate testing for viral hepatitis, sexually transmitted diseases (STDs), and tuberculosis (TB) with HIV testing and prevention services.
Leverage resources to maximize the yield and sustainability of routine HIV screening programs in healthcare settings.

Program Goals and Objectives

What’s new?

In alignment with the National HIV/AIDS Strategy, this health department funding opportunity used a funding formula based on disease burden for allocating core HIV prevention resources to better match the geographic burden of the U.S. HIV epidemic. Funding Opportunity Announcement PS12-1201, Category B has included:

Prioritized high impact HIV prevention activities.
The approximate first-year funding for Part B is $54.8 million in FY 2012.
Expanded eligibility: State and local health departments or their Bona Fide agents in jurisdictions with at least 3,000 Black/African American and Hispanic/Latino residents living with an HIV diagnosis in 2008 were eligible to apply. This includes 24 states, the District of Columbia, Puerto Rico, and ten directly funded cities: Atlanta, Baltimore, Chicago, Fort Lauderdale, Houston, Los Angeles, Miami, New York, Philadelphia, and San Francisco
New program goals and objectives: Conduct approximately 1.1 million tests and find at least 5,500 new HIV cases in the first year of funding. After full implementation, conduct at least 1.3 million tests and find at least 6,500 new HIV cases annually.
Targeting populations with the highest HIV burden: African-American and Hispanic men and women; and men who have sex with men (MSM) and injection drug users (IDUs), regardless of race or ethnicity.
Flexibility in venue selection: Allows funding ratio of 70/30 between healthcare and non-healthcare settings respectively (i.e., at least 70% of program funds must be allocated to activities in healthcare settings and up to 30% may be allocated to activities in non-healthcare settings). The objective is for targeted Counseling, Testing, and Referral (CTR) in non-healthcare settings or venues to achieve at least a 2.0% rate of newly identified HIV-positive tests annually.
Integration of screening for STDs, hepatitis, and TB in conjunction with HIV screening.
Enhanced program monitoring and evaluation plan.
Enhanced provision and tracking of technical assistance/training.
New data collection mechanisms.
Enhanced coordination and collaboration among all stakeholders.
Adoption of sustainable, routine HIV testing programs in healthcare facilities consistent with CDC's 2006 Revised Recommendations for HIV Testing of Adults, Adolescents, and Pregnant Women in Health-Care Settings.

Highlights from Funding Opportunity Announcement PS10-10138
This new Funding Opportunity Announcement represents an extension of the PS07-768, a 3-year program that concluded on September 29, 2010 and PS10-10138, a 15-month program that concluded on December 30, 2012.

CDC is pleased with the overall success of PS10-10138. Highlights from the first year of PS10-10138 as self-reported by funded grantees in their Annual Progress Reports include the following:

Conducted over 1.49 million HIV tests.
Identified over 7,000 persons with newly diagnosed HIV infection. Successfully targeted African Americans: approximately 51% of tests and 61% of new positive tests were among African Americans.
Initiated routine HIV screening programs in a variety of new healthcare settings, including emergency departments, STD clinics, TB clinics, state and local jails, urgent care clinics, and community health centers
Successfully targeted African Americans: approximately 65% of tests were among African Americans.
Among newly diagnosed HIV positives, approximately 79% were referred to care, 61% were linked to care, 74% were referred for prevention counseling, and 56% received partner services.
Achieved high success rates in linking persons with newly diagnosed HIV infection to medical care and partner services.
Strengthened public health and preventive care infrastructure, particularly in venues and communities serving disproportionately affected populations



	About Us Background In the summer of 2011, the Prevention Program Branch published Funding Opportunity Announcement PS12-1201, Category B: Expanded Human Immunodeficiency Virus (HIV) Testing for Disproportionately Affected Populations. Main Features PS12-1201 Category B includes two components: Routine, opt-out HIV screening in healthcare settings serving the target populations (at least 70 percent of funding); and Targeted HIV testing in non-healthcare venues frequented by high-risk individuals (up to 30 percent of funding). Purpose: Increase HIV testing opportunities for populations disproportionately affected by HIV - African-Americans, Hispanics, men who have sex with men (MSM) and injection drug users (IDUs), primarily in healthcare settings and expand targeted testing in non-healthcare settings and venues where high-risk members of these populations can be accessed. Increase the proportion of HIV-infected persons in these populations who are aware of their infection and are linked to appropriate services, such as prevention counseling and HIV medical care, partner services, and HIV prevention services. Integrate testing for viral hepatitis, sexually transmitted diseases (STDs), and tuberculosis (TB) with HIV testing and prevention services. Leverage resources to maximize the yield and sustainability of routine HIV screening programs in healthcare settings. Program Goals and Objectives What’s new? In alignment with the National HIV/AIDS Strategy, this health department funding opportunity used a funding formula based on disease burden for allocating core HIV prevention resources to better match the geographic burden of the U.S. HIV epidemic. Funding Opportunity Announcement PS12-1201, Category B has included: Prioritized high impact HIV prevention activities. The approximate first-year funding for Part B is $54.8 million in FY 2012. Expanded eligibility: State and local health departments or their Bona Fide agents in jurisdictions with at least 3,000 Black/African American and Hispanic/Latino residents living with an HIV diagnosis in 2008 were eligible to apply. This includes 24 states, the District of Columbia, Puerto Rico, and ten directly funded cities: Atlanta, Baltimore, Chicago, Fort Lauderdale, Houston, Los Angeles, Miami, New York, Philadelphia, and San Francisco New program goals and objectives: Conduct approximately 1.1 million tests and find at least 5,500 new HIV cases in the first year of funding. After full implementation, conduct at least 1.3 million tests and find at least 6,500 new HIV cases annually. Targeting populations with the highest HIV burden: African-American and Hispanic men and women; and men who have sex with men (MSM) and injection drug users (IDUs), regardless of race or ethnicity. Flexibility in venue selection: Allows funding ratio of 70/30 between healthcare and non-healthcare settings respectively (i.e., at least 70% of program funds must be allocated to activities in healthcare settings and up to 30% may be allocated to activities in non-healthcare settings). The objective is for targeted Counseling, Testing, and Referral (CTR) in non-healthcare settings or venues to achieve at least a 2.0% rate of newly identified HIV-positive tests annually. Integration of screening for STDs, hepatitis, and TB in conjunction with HIV screening. Enhanced program monitoring and evaluation plan. Enhanced provision and tracking of technical assistance/training. New data collection mechanisms. Enhanced coordination and collaboration among all stakeholders. Adoption of sustainable, routine HIV testing programs in healthcare facilities consistent with CDC's 2006 Revised Recommendations for HIV Testing of Adults, Adolescents, and Pregnant Women in Health-Care Settings. Highlights from Funding Opportunity Announcement PS10-10138 This new Funding Opportunity Announcement represents an extension of the PS07-768, a 3-year program that concluded on September 29, 2010 and PS10-10138, a 15-month program that concluded on December 30, 2012. CDC is pleased with the overall success of PS10-10138. Highlights from the first year of PS10-10138 as self-reported by funded grantees in their Annual Progress Reports include the following: Conducted over 1.49 million HIV tests. Identified over 7,000 persons with newly diagnosed HIV infection. Successfully targeted African Americans: approximately 51% of tests and 61% of new positive tests were among African Americans. Initiated routine HIV screening programs in a variety of new healthcare settings, including emergency departments, STD clinics, TB clinics, state and local jails, urgent care clinics, and community health centers Successfully targeted African Americans: approximately 65% of tests were among African Americans. Among newly diagnosed HIV positives, approximately 79% were referred to care, 61% were linked to care, 74% were referred for prevention counseling, and 56% received partner services. Achieved high success rates in linking persons with newly diagnosed HIV infection to medical care and partner services. Strengthened public health and preventive care infrastructure, particularly in venues and communities serving disproportionately affected populations
© 2012 Created byCDC NPIN